The All India Institute of Medical Sciences (AIIMS) and the Indian Council of Medical Research (ICMR) Covid-19 national task force has made the recommendation to drop the use of these two drugs in its revised guidelines.
The reasons behind dropping Hydroxychloroquine also included no mortality benefit, increases the risk of address drug effect (ADE) when co-administered with Azithromycin
World Health Organisation temporarily stopped the clinical trials of the medicine last week after fears that it may in fact worsen coronavirus patient's outcomes.
However, the chemicals in Kangra tea could also be effective in boosting immunity as they can block coronavirus activity better than anti-HIV drugs, said Dr Sanjay Kumar, Director, Institute of Himalayan Bioresource Technology (IHBT), based in Palampur, Himachal Pradesh.
India, during late last month, had issued an order reopening restricting the export of HCQ and paracetamol on "case-by-case" basis.
